PMC:7558914 / 8896-9148
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
189 | 0-8 | Species | denotes | Patients | Tax:9606 |
192 | 49-67 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
193 | 71-90 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
194 | 110-128 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
195 | 134-146 | Chemical | denotes | azithromycin | MESH:D017963 |
196 | 150-169 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
197 | 194-212 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
198 | 214-226 | Chemical | denotes | azithromycin | MESH:D017963 |
199 | 232-251 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T56 | 0-252 | Sentence | denotes | Patients could be treated with monotherapy using hydroxychloroquine or lopinavir/ritonavir; dual therapy with hydroxychloroquine plus azithromycin or lopinavir/ritonavir; or triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir. |